DNA aptamer technology for personalized medicine

Hang Xing, Kevin Hwang, Ji Li, Seyed Fakhreddin Torabi, Yi Lu

Research output: Contribution to journalReview article


This review highlights recent progress in developing DNA aptamers for personalized medicine, with more focus on in vivo studies for potential clinical applications. Examples include design of aptamers in combination with DNA nanostructures, nanomaterials, or microfluidic devices as diagnostic probes or therapeutic agents for cancers and other diseases. The use of aptamers as targeting agents in drug delivery is also covered. The advantages and future directions of such DNA aptamer-based technology for the continued development of personalized medicine are discussed.

Original languageEnglish (US)
Pages (from-to)79-87
Number of pages9
JournalCurrent Opinion in Chemical Engineering
StatePublished - May 2014


ASJC Scopus subject areas

  • Energy(all)

Cite this